Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care.

Biotechnology

Karuna Therapeutics

Bill Meury

Susan Mulvaney

Briana Lauziere

Tara T.

Steven Paul

Tanya Glidden

Amanda Orban

Stephanie Hodges

Alicia Meli

Frank Truslow

Jackie Cohen

Mia Kelley

Will Kane

Andrew Miller

Troy A. Ignelzi

Stephen Brannan

Medical and Clinical Operations

Directors

Leadership Team

Advisory Board

Regulatory and Compliance Team

Scientific and Research Team

Human Resources Team

Finance

Legal and Contracts Team

Teams at Karuna Therapeutics